Link Pharma Chem Limited / Fundamentals
Income statement
- Net revenue
€2.65M - Cost of goods sold
€1.59M - Gross profit
€1.05M - SG&A expenses
€375.00K - R&D expenses
€0.00 - EBITDA
€130.31K - D&A
€93.62K - EBIT
€31.01K - Interest expenses
€81.18K - EBT
-€44.48K - Tax expenses
-€3.64K - Net income
-€40.84K
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
€40.84K - Changes in working capital
€0.00 - Operating cash flow
€0.00 - Capex
€0.00 - Other investing cash flow
€0.00 - Net investing cash flow
€0.00 - Total cash dividends paid
€0.00 - Issuance of common stock
€0.00 - Debt repayment
€0.00 - Other financing cash flow
€0.00 - Net financing cash flow
€0.00 - Foreign exchange effects
€0.00 - Net change in cash
€0.00 - Cash at end of period
€0.00 - Free cash flow
€0.00
Balance sheet
- Cash and cash equivalents
€0.00 - Cash and short-term investments
€177.76K - Total receivables
€0.00 - Inventory
€0.00 - Other current assets
-€177.76K - Total current assets
€0.00 - Property, plant & equipment
€0.00 - Goodwill
€0.00 - Intangible assets
€0.00 - Long-term investments
€0.00 - Other non-current assets
€0.00 - Total non-current assets
€0.00 - Total assets
€0.00 - Accounts payable
€0.00 - Short-term debt
€0.00 - Other current liabilities
€0.00 - Total current liabilities
€0.00 - Long-term debt
€0.00 - Deferred tax liabilities
€0.00 - Other non-current liabilities
-€1.34M - Total non-current liabilities
-€1.34M - Total liabilities
-€1.34M - Common stock
€0.00 - Retained earnings
€0.00 - Other equity
€1.34M - Total equity
€1.34M - Total liabilities and shareholders' equity
€0.00
Company information
- Market capitalization
€1.66M - Employees
87 - Enterprise Value
€239.64M
Company ratios
- Gross margin
-
39.8% - EBITDA margin
-
4.9% - EBIT margin
-
1.2% - EBT margin
-
-1.7% - Net margin
-
-1.5% - ROE
-
-3.0% - ROA
-
0.0% - Asset turnover
-
0.0% - FCF margin
-
0.0% - FCF yield
0.0% - Efficiency ratio
95.1% - Net sales per employee
-
€30.42K - Net income per employee
-
-€469.42